Palvella Therapeutics (PVLA)
Develops topical QTORIN candidates for serious rare skin diseases and vascular malformations.
$148.10
vs last close−10.03 (−6.35%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | ≈ 96.62% | 13.92M shares | |
|---|---|---|---|
| 208 holders · as of Jun 30, 2026 · largest filers plus last quarter's tail | |||
| Insiders | 8.10% | 1.17M shares | |
| 6 holders · as of Sep 15, 2026 | |||
| Strategic holders | 6.95% | 1.00M shares | |
| 2 holders · as of Aug 10, 2026 | |||
| Adds to | 111.67% | ||
14.41M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
This quarter's institutional total failed a plausibility check; shown: the largest filers plus last quarter's remainder.
These groups come from separate filings that can overlap, so they add to 111.67%; nothing is left for Other.
13F, as of Jun 30, 2026
208 holders · 13.92M shares · 41 new positions · 127 increased · 45 reduced · 23 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Suvretta Capital Management, LLC | 1.14M | 7.88% | −18.1K | Aug 14, 2026 |
| Jennison Associates LLC | 960.6K | 6.67% | +320.0K | Aug 3, 2026 |
| BlackRock, Inc. | 918.4K | 6.37% | +231.5K | Aug 7, 2026 |
| Frazier Life Sciences Management, L.P. | 882.4K | 6.12% | 0 | Aug 14, 2026 |
| First Light Asset Management, LLC | 771.9K | 5.36% | −208.9K | Aug 14, 2026 |
| BVF Inc/IL | 672.8K | 4.67% | −288.2K | Aug 14, 2026 |
| State Street Corp | 653.2K | 4.53% | +194.2K | Aug 7, 2026 |
| Price T Rowe Associates Inc /MD/ | 638.9K | 4.43% | +236.3K | Aug 14, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| First Light Asset Management, LLC | 7.49% | 887.0K | 13G | Feb 17, 2026 |
| Suvretta Capital Management, LLC | 7.40% | 822.4K | 13G | Nov 13, 2025 |
| Prudential Financial Inc | 6.70% | 962.4K | 13G | Aug 10, 2026 |
| Jennison Associates LLC | 6.70% | 960.6K | 13G | Aug 3, 2026 |
| Frazier Life Sciences Public Fund, L.P. | 6.00% | 706.4K | 13G | Feb 13, 2026 |
| BlackRock, Inc. | 5.70% | 813.0K | 13G | Jul 29, 2026 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Sep 16, 2026 | Kathleen Goinofficer: Chief Operating Officer | Sale · 3 lots | 4,302 | $152.24 | 0 |
| Sep 15, 2026 | George M. Jenkinsdirector | Sale · 3 lots | 1,777 | $150.14 | 160,116 |
| Sep 14, 2026 | George M. Jenkinsdirector | Sale · 3 lots | 13,352 | $151.96 | 161,893 |
| Sep 11, 2026 | George M. Jenkinsdirector | Sale · 3 lots | 12,371 | $151.28 | 175,245 |
| Sep 2, 2026 | Christopher P. Kiritsydirector | Sale | 313 | $157.00 | 250 |
| Aug 19, 2026 | Kathleen Goinofficer: Chief Operating Officer | Sale · 5 lots | 4,302 | $152.21 | 0 |
| Jul 15, 2026 | Kathleen Goinofficer: Chief Operating Officer | Sale · 4 lots | 4,302 | $149.28 | 0 |
| Jun 17, 2026 | Kathleen Goinofficer: Chief Operating Officer | Sale · 3 lots | 4,302 | $110.73 | 0 |
| May 20, 2026 | Kathleen Goinofficer: Chief Operating Officer | Sale · 3 lots | 4,302 | $110.56 | 0 |
| Apr 15, 2026 | Kathleen Goinofficer: Chief Operating Officer | Sale · 5 lots | 4,302 | $127.24 | 0 |
House and Senate disclosures
Not reported.